Terms ending in 2032
Otsuka Pharmaceutical Co., Ltd.
Every in-force patent on Otsuka Pharmaceutical Co., Ltd.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,357,586 | Use of the Phytocannabinoid Cannabidiol (CBD) in Combination with a Standard Anti-Epileptic Drug (SAED) in the Treatment of Epilepsy In force · Medium confidence | Jazz Pharmaceuticals Operations UK Limited | In force | Medium confidence | |
| US 9,439,599 | Wearable Personal Body Associated Device with Various Physical Configurations In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 9,006,686 | Surface Plasmon Resonance Fluorescence Analysis Device and Surface Plasmon Resonance Fluorescence Analysis Method In force · High confidence | Konica Minolta, Inc. | In force | High confidence | |
| US 9,623,054 | Agent for Improving or Maintaining Qol In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,369,177 | Agent for Improving or Maintaining Qol In force · Medium confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 9,895,342 | Cannabinoids for Use in the Treatment of Neuropathic Pain In force · High confidence | Jazz Pharmaceuticals Operations UK Limited | In force | High confidence | |
| US 9,066,920 | Use of One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy In force · High confidence | Jazz Pharmaceuticals Operations UK Limited | In force | High confidence | |
| US 9,068,945 | Surface Plasmon-Field Enhanced Fluorescence Spectroscopic Measurement Method and Surface Plasmon-Field Enhanced Fluorescence Spectroscopic Measurement Device In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,154,507 | Freeze-Dried Aripiprazole Formulation In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 8,912,908 | Communication System with Remote Activation In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| 12 more term ends in 2032 · Pro | |||||
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
15 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.